InvestorsHub Logo
icon url

zombywolf

06/29/18 12:46 PM

#47995 RE: Scruffer #47994

Good read, Scruff! IMO, the IPR denial sets everything into motion.
icon url

Scruffer

06/29/18 2:47 PM

#48002 RE: Scruffer #47994

ARRIS is quite indebted, but has $3B+

Weird 10-K, 10-Q.

Looking for Change in Cash Flow From Operations.

"As of December 31, 2017, we had approximately $2,161.4 million in total indebtedness and $498.3 million available under our revolving line of credit to support our working capital needs. Our debt service obligations with respect to this indebtedness could have an adverse impact on our earnings and cash flows for as long as the indebtedness is outstanding."

Anyway, makes it harder to go to trial. Can't afford risk of $3x.

Believe must buy. No other practical option.

In addition, maybe they have insurance policy to hedge against infringement.

Couldn't find, but my research time is up.

Scruff

icon url

Goodbuddy4863

06/29/18 4:31 PM

#48015 RE: Scruffer #47994

WOW...when ARRIS is denied = Big Pay day for ChanBond[UOIP} and all of us.

How good does it get!